Page last updated: 2024-09-02

fingolimod hydrochloride and Carcinoma, Basal Cell, Pigmented

fingolimod hydrochloride has been researched along with Carcinoma, Basal Cell, Pigmented in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Gębka-Kępińska, B; Sowa, P; Zięba, N	1

Reviews

1 review(s) available for fingolimod hydrochloride and Carcinoma, Basal Cell, Pigmented

Article	Year
BASAL CELL CARCINOMA AND SQUAMOUS CELL CARCINOMA IN A PATIENT TREATED WITH FINGOLIMOD FOR MULTIPLE SCLEROSIS - A CASE REPORT AND LITERATURE REVIEW. Wiadomosci lekarskie (Warsaw, Poland : 1960), 2022, Volume: 75, Issue:3 Topics: Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Male; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Neoplasm Recurrence, Local; Skin Neoplasms	2022

Article

Year

BASAL CELL CARCINOMA AND SQUAMOUS CELL CARCINOMA IN A PATIENT TREATED WITH FINGOLIMOD FOR MULTIPLE SCLEROSIS - A CASE REPORT AND LITERATURE REVIEW.

Wiadomosci lekarskie (Warsaw, Poland : 1960), 2022, Volume: 75, Issue:3

Topics: Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Male; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Neoplasm Recurrence, Local; Skin Neoplasms

2022